The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
Open accessAbstract
The care for patients with cancer has advanced greatly over the past decades. A combination of earlier cancer diagnosis and greater use of traditional and novel systemic treatments has decreased cancer-related mortality. Effective cancer therapies, however, can result in short- and long-term co-morbidities that can decrease the net clinical gain by impacting quality of life and survival. In particular, cardiovascular complications of cancer treatments can have a profound impact on the health of cancer patients and are more common among those with recognized or unrecognized underlying cardiovascular diseases. A new discipline termed “cardio-oncology” has thus evolved to address the cardiovascular needs of cancer patients and optimize their care in a multidisciplinary approach. This review provides a brief introduction and background on this emerging field and then focuses on its practical aspects including: cardiovascular risk assessment and prevention before cancer treatment, cardiovascular surveillance and therapy during cancer treatment, and cardiovascular monitoring and management after cancer therapy. The content of this review is based on a literature search of PubMed between January 1, 1960, and February 1, 2014 using the search terms cancer, cardiomyopathy, cardiotoxicity, cardio-oncology, chemotherapy, heart failure, and radiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209825 · Cited by 3,974
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Cella, D., Reeves, J., Hawkins, R., Guo, J., Nathan, P., Staehler, M., de Souza, P., Merchan, J. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303989 · Cited by 1,923
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,723
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
Seidman, A. D., Hudis, C. A., Pierri, M. K., Shak, S., Paton, V. E., Ashby, M. A., Murphy, M., Stewart, S. J., & Keefe, D. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1215 · Cited by 1,563
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
Lipshultz, S. E., Colan, S. D., Gelber, R. D., Perez-Atayde, A. R., Sallan, S. E., & Sanders, S. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241205 · Cited by 1,404
Cardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
Mulrooney, D. A., Yeazel, M. W., Kawashima, T., Mertens, A. C., Mitby, P., Stovall, M., Donaldson, S. S., Green, D. M., Sklar, C. A., Robison, L. L., et al. (2009) · BMJ · doi:10.1136/bmj.b4606 · Cited by 1,166
Anthracycline-Induced Cardiomyopathy
Cardinale, D., Colombo, A., Lamantia, G., Colombo, N., Civelli, M., De Giacomi, G., Rubino, M., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.095 · Cited by 1,105
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Chu, T. F., Rupnick, M. A., Kerkela, R., Dallabrida, S. M., Zurakowski, D., Nguyen, L., Woulfe, K., Pravda, E., Cassiola, F., Desai, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61865-0 · Cited by 1,083
More ‘Malignant’ Than Cancer? Five-Year Survival Following a First Admission for Heart Failure
Stewart, S., MacIntyre, K., Hole, D. J., Capewell, S., & McMurray, J. J. V. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00141-0 · Cited by 1,050
Bellenger, N. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2011 · Cited by 1,040
Cardinale, D., Colombo, A., Sandri, M. T., Lamantia, G., Colombo, N., Civelli, M., Martinelli, G., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2006) · Circulation · doi:10.1161/circulationaha.106.635144 · Cited by 1,026
Swain, S. M., Kim, S.-B., Cortés, J., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Knott, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70130-x · Cited by 1,006
ErbB2 is essential in the prevention of dilated cardiomyopathy
Crone, S. A., Zhao, Y.-Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K. L., Chen, J., Kahn, R., Condorelli, G., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-459 · Cited by 903
Curigliano, G., Cardinale, D., Suter, T., Plataniotis, G., de Azambuja, E., Sandri, M. T., Criscitiello, C., Goldhirsch, A., Cipolla, C., & Roila, F. (2012) · Annals of Oncology · doi:10.1093/annonc/mds293 · Cited by 865
Treatment of HER2-positive breast cancer: current status and future perspectives
Arteaga, C. L., Sliwkowski, M. X., Osborne, C. K., Perez, E. A., Puglisi, F., & Gianni, L. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.177 · Cited by 861
Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer
Hooning, M. J., Botma, A., Aleman, B. M. P., Baaijens, M. H. A., Bartelink, H., Klijn, J. G. M., Taylor, C. W., & van Leeuwen, F. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk064 · Cited by 861
Cardiovascular Complications of Cancer Therapy: Diagnosis, Pathogenesis, and Management
Yeh, E. T. H., Tong, A. T., Lenihan, D. J., Yusuf, S. W., Swafford, J., Champion, C., Durand, J.-B., Gibbs, H., Zafarmand, A. A., & Ewer, M. S. (2004) · Circulation · doi:10.1161/01.cir.0000133187.74800.b9 · Cited by 843
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Albini, A., Pennesi, G., Donatelli, F., Cammarota, R., De Flora, S., & Noonan, D. M. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp440 · Cited by 839
Sawaya, H., Sebag, I. A., Plana, J. C., Januzzi, J. L., Ky, B., Tan, T. C., Cohen, V., Banchs, J., Carver, J. R., Wiegers, S. E., et al. (2012) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.973321 · Cited by 814
Lipshultz, S. E., Lipsitz, S. R., Mone, S. M., Goorin, A. M., Sallan, S. E., Sanders, S. P., Orav, E. J., Gelber, R. D., & Colan, S. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322602 · Cited by 803
Anthracycline-Induced Cardiotoxicity
Shan, K., Lincoff, A. M., & Young, J. B. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00008 · Cited by 749
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Dalton, V. M., Mone, S. M., Gelber, R. D., & Colan, S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.121 · Cited by 727
Ewer, M. S., Vooletich, M. T., Durand, J.-B., Woods, M. L., Davis, J. R., Valero, V., & Lenihan, D. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.300 · Cited by 726
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Thavendiranathan, P., Grant, A. D., Negishi, T., Plana, J. C., Popović, Z. B., & Marwick, T. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.035 · Cited by 689
Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity
Ewer, M. S., & Lippman, S. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.827 · Cited by 646
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
Cardinale, D., Colombo, A., Torrisi, R., Sandri, M. T., Civelli, M., Salvatici, M., Lamantia, G., Colombo, N., Cortinovis, S., Dessanai, M. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3615 · Cited by 641
Bosch, X., Rovira, M., Sitges, M., Domènech, A., Ortiz-Pérez, J. T., de Caralt, T. M., Morales-Ruiz, M., Perea, R. J., Monzó, M., & Esteve, J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.072 · Cited by 632
Ky, B., Putt, M., Sawaya, H., French, B., Januzzi, J. L., Sebag, I. A., Plana, J. C., Cohen, V., Banchs, J., Carver, J. R., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.061 · Cited by 563
Cardioprotective interventions for cancer patients receiving anthracyclines
van Dalen, E. C., Caron, H. N., Dickinson, H. O., & Kremer, L. C. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003917.pub4 · Cited by 553
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
Cardinale, D., Sandri, M. T., Martinoni, A., Tricca LabTech, A., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Cipolla, C. M., & Fiorentini, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00748-8 · Cited by 551
Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide Angiocardiography
Alexander, J., Dainiak, N., Berger, H. J., Goldman, L., Johnstone, D., Reduto, L., Duffy, T., Schwartz, P., Gottschalk, A., Zaret, B. L., et al. (1979) · New England Journal of Medicine · doi:10.1056/nejm197902083000603 · Cited by 535
Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy
Schwartz, R. G., McKenzie, W. B., Alexander, J., Sager, P., D'Souza, A., Manatunga, A., Schwartz, P. E., Berger, H. J., Setaro, J., Surkin, L., et al. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90212-9 · Cited by 510
Cardiovascular Status in Long-Term Survivors of Hodgkin's Disease Treated With Chest Radiotherapy
Adams, M. J., Lipsitz, S. R., Colan, S. D., Tarbell, N. J., Treves, S. T., Diller, L., Greenbaum, N., Mauch, P., & Lipshultz, S. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.109 · Cited by 500
Goldhirsch, A., Gelber, R. D., Piccart-Gebhart, M. J., de Azambuja, E., Procter, M., Suter, T. M., Jackisch, C., Cameron, D., Weber, H. A., Heinzmann, D., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61094-6 · Cited by 497
Cardiotoxicity Associated With High-Dose Cyclophosphamide Therapy
Gottdiener, J. S. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.6.758 · Cited by 486
Fallah-Rad, N., Walker, J. R., Wassef, A., Lytwyn, M., Bohonis, S., Fang, T., Tian, G., Kirkpatrick, I. D. C., Singal, P. K., Krahn, M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.063 · Cited by 484
Lancellotti, P., Nkomo, V. T., Badano, L. P., Bergler, J., Bogaert, J., Davin, L., Cosyns, B., Coucke, P., Dulgheru, R., Edvardsen, T., et al. (2013) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2013.07.005 · Cited by 484
Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer
Tukenova, M., Guibout, C., Oberlin, O., Doyon, F., Mousannif, A., Haddy, N., Guérin, S., Pacquement, H., Aouba, A., Hawkins, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.2267 · Cited by 451
The incidence and functional consequences of RT-associated cardiac perfusion defects
Marks, L. B., Yu, X., Prosnitz, R. G., Zhou, S.-M., Hardenbergh, P. H., Blazing, M., Hollis, D., Lind, P., Tisch, A., Wong, T. Z., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.029 · Cited by 436
Adriamycin-induced oxidative mitochondrial cardiotoxicity
Berthiaume, J. M., & Wallace, K. B. (2007) · Cell Biology and Toxicology · doi:10.1007/s10565-006-0140-y · Cited by 409
Stewart, J. R., Fajardo, L. F., Gillette, S. M., & Constine, L. S. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00656-6 · Cited by 403
Cardiac Complications of Thoracic Irradiation
Jaworski, C., Mariani, J. A., Wheeler, G., & Kaye, D. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.090 · Cited by 393
Correa, C. R., Litt, H. I., Hwang, W.-T., Ferrari, V. A., Solin, L. J., & Harris, E. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6595 · Cited by 392
Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials
Perez, E. A., Koehler, M., Byrne, J., Preston, A. J., Rappold, E., & Ewer, M. S. (2008) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60896-3 · Cited by 388
Pathology of radiation-induced heart disease: A surgical and autopsy study of 27 cases
VEINOT, J. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90447-5 · Cited by 385
One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
Do, D. V., Nguyen, Q. D., Boyer, D., Schmidt-Erfurth, U., Brown, D. M., Vitti, R., Berliner, A. J., Gao, B., Zeitz, O., Ruckert, R., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.02.010 · Cited by 385
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
Ewer, M. S., & Ewer, S. M. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.121 · Cited by 373
Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
Lotrionte, M., Biondi-Zoccai, G., Abbate, A., Lanzetta, G., D'Ascenzo, F., Malavasi, V., Peruzzi, M., Frati, G., & Palazzoni, G. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.026 · Cited by 371
Giordano, F. J., Gerber, H.-P., Williams, S.-P., VanBruggen, N., Bunting, S., Ruiz-Lozano, P., Gu, Y., Nath, A. K., Huang, Y., Hickey, R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091415198 · Cited by 370
Jensen, B. V., Skovsgaard, T., & Nielsen, S. L. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf132 · Cited by 336
Seicean, S., Seicean, A., Plana, J. C., Budd, G. T., & Marwick, T. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.067 · Cited by 326
Kaya, M. G., Ozkan, M., Gunebakmaz, O., Akkaya, H., Kaya, E. G., Akpek, M., Kalay, N., Dikilitas, M., Yarlioglues, M., Karaca, H., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.023 · Cited by 325
High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors
van der Pal, H. J., van Dalen, E. C., van Delden, E., van Dijk, I. W., Kok, W. E., Geskus, R. B., Sieswerda, E., Oldenburger, F., Koning, C. C., van Leeuwen, F. E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.4730 · Cited by 320
Silber, J. H., Cnaan, A., Clark, B. J., Paridon, S. M., Chin, A. J., Rychik, J., Hogarty, A. N., Cohen, M. I., Barber, G., Rutkowski, M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.022 · Cited by 299
Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab
Choueiri, T. K., Mayer, E. L., Je, Y., Rosenberg, J. E., Nguyen, P. L., Azzi, G. R., Bellmunt, J., Burstein, H. J., & Schutz, F. A. B. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.9129 · Cited by 293
Stewart, F. A., Heeneman, S., te Poele, J., Kruse, J., Russell, N. S., Gijbels, M., & Daemen, M. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050409 · Cited by 286
Lemmens, K., Doggen, K., & De Keulenaer, G. W. (2007) · Circulation · doi:10.1161/circulationaha.107.690487 · Cited by 286
Yu, E., Calvert, P. A., Mercer, J. R., Harrison, J., Baker, L., Figg, N. L., Kumar, S., Wang, J. C., Hurst, L. A., Obaid, D. R., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002271 · Cited by 283
Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease
Heidenreich, P. A., Schnittger, I., Strauss, H. W., Vagelos, R. H., Lee, B. K., Mariscal, C. S., Tate, D. J., Horning, S. J., Hoppe, R. T., & Hancock, S. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0805 · Cited by 262
Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy
Acar, Z., Kale, A., Turgut, M., Demircan, S., Durna, K., Demir, S., Meriç, M., & Ağaç, M. T. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.025 · Cited by 255
Kerkela, R., Woulfe, K. C., Durand, J., Vagnozzi, R., Kramer, D., Chu, T. F., Beahm, C., Chen, M. H., & Force, T. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00090.x · Cited by 242
Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
Telli, M. L., Witteles, R. M., Fisher, G. A., & Srinivas, S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn168 · Cited by 237
Georgakopoulos, P., Roussou, P., Matsakas, E., Karavidas, A., Anagnostopoulos, N., Marinakis, T., Galanopoulos, A., Georgiakodis, F., Zimeras, S., Kyriakidis, M., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21840 · Cited by 222
Overview of cardiac pathology in relation to anthracycline cardiotoxicity.
Ferrans, V. J. (1978) · PubMed · Cited by 219
Role of iron in anthracycline cardiotoxicity: new tunes for an old song?
MINOTTI, G., CAIRO, G., & MONTI, E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.199 · Cited by 214
Hoffmann, R., Barletta, G., von Bardeleben, S., Vanoverschelde, J. L., Kasprzak, J., Greis, C., & Becher, H. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2013.12.005 · Cited by 212
Poterucha, J. T., Kutty, S., Lindquist, R. K., Li, L., & Eidem, B. W. (2012) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2012.04.007 · Cited by 207
Hall, P. S., Harshman, L. C., Srinivas, S., & Witteles, R. M. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.09.001 · Cited by 207
Di Lorenzo, G., Autorino, R., Bruni, G., Cartenì, G., Ricevuto, E., Tudini, M., Ficorella, C., Romano, C., Aieta, M., Giordano, A., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp025 · Cited by 207
Groarke, J. D., Nguyen, P. L., Nohria, A., Ferrari, R., Cheng, S., & Moslehi, J. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht114 · Cited by 193
Understanding Radiation-Induced Vascular Disease
Weintraub, N. L., Jones, W. K., & Manka, D. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.053 · Cited by 187
Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies
Ky, B., Vejpongsa, P., Yeh, E. T. H., Force, T., & Moslehi, J. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.300218 · Cited by 170
Nousiainen, T., Jantunen, E., Vanninen, E., & Hartikainen, J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600346 · Cited by 165
Seicean, S., Seicean, A., Alan, N., Plana, J. C., Budd, G. T., & Marwick, T. H. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000055 · Cited by 165
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper
Aapro, M., Bernard-Marty, C., Brain, E. G. C., Batist, G., Erdkamp, F., Krzemieniecki, K., Leonard, R., Lluch, A., Monfardini, S., Ryberg, M., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq609 · Cited by 164
Delayed Contrast Enhancement on MR Images of Myocardium: Past, Present, Future
Ordovas, K. G., & Higgins, C. B. (2011) · Radiology · doi:10.1148/radiol.11091882 · Cited by 163
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
Serrano, C., Cortés, J., De Mattos-Arruda, L., Bellet, M., Gómez, P., Saura, C., Pérez, J., Vidal, M., Muñoz-Couselo, E., Carreras, M. J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr348 · Cited by 161
DNA damage and repair in atherosclerosis
Mahmoudi, M., Mercer, J., & Bennett, M. R. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.03.002 · Cited by 155
Long-Term Survival of Patients With Radiation Heart Disease Undergoing Cardiac Surgery
Wu, W., Masri, A., Popović, Z., Smedira, N. G., Lytle, B. W., Marwick, T. H., Griffin, B. P., & Desai, M. Y. (2013) · Circulation · doi:10.1161/circulationaha.113.001435 · Cited by 154
Fallah‐Rad, N., Lytwyn, M., Fang, T., Kirkpatrick, I. D., & Jassal, D. S. (2008) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-10-5 · Cited by 152
Ylänen, K., Poutanen, T., Savikurki-Heikkilä, P., Rinta-Kiikka, I. C., Eerola, A., & Vettenranta, K. K. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.019 · Cited by 141
Martín, M., Esteva, F. J., Alba, E., Khandheria, B. K., de Isla, L. P., García-Sáenz, J. Á., Márquez, A., Sengupta, P. P., & Zamorano, J. L. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0137 · Cited by 141
Seemann, I., Gabriels, K., Visser, N. L., Hoving, S., Poele, J. A. M. T., Pol, J. F., Gijbels, M. J., Janssen, B. J., van Leeuwen, F. W. B., Daemen, M. J. A. P., et al. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.10.011 · Cited by 137
Herrmann, J., Lerman, L. O., Mukhopadhyay, D., Claudio Napoli, A., & Lerman, A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000233387.90257.9b · Cited by 129
Self-citationPooled analysis of cardiac safety in patients with cancer treated with pertuzumab
Lenihan, D. J., Suter, T. M., Brammer, M. G., Neate, C., Ross, G. A., & Baselga, J. M. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr294 · Cited by 120
Oliveira, G. H., Dupont, M., Naftel, D. C., Myers, S. L., Yuan, Y., Tang, W. H. W., Gonzalez‐Stawinski, G. V., Young, J. B., Taylor, D. O., & Starling, R. C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.040 · Cited by 119
Role of mtDNA lesions in anthracycline cardiotoxicity
Lebrecht, D., & Walker, U. A. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0009-1 · Cited by 115
El‐Shitany, N. A., Tolba, O., El-Shanshory, M. R., & Elhawary, E. E. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.06.416 · Cited by 109
Pathology of radiation and anthracycline cardiotoxicity
Berry, G. J., & Jorden, M. A. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20346 · Cited by 107
Impact of Coronary Artery Calcium Characteristics on Accuracy of CT Angiography
Kruk, M. B. P., Noll, D., Achenbach, S., Mintz, G. S., Pręgowski, J., Kaczmarska, E., Kryczka, K., Pracoń, R., Dzielińska, Z., Śleszycka, J., et al. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.07.013 · Cited by 105
Schwartz, R. G., Jain, D., & Storozynsky, E. (2013) · Journal of Nuclear Cardiology · doi:10.1007/s12350-013-9707-1 · Cited by 97
Differential cardioprotective/cardiotoxic effects mediated by β-adrenergic receptor subtypes
Bernstein, D., Fajardo, G., Zhao, M., Urashima, T., Powers, J. C., Berry, G. J., & Kobilka, B. K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00005.2005 · Cited by 92
Fine, N. M., Crowson, C. S., Lin, G., Oh, J. K., Villarraga, H. R., & Gabriel, S. E. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203314 · Cited by 90
Self-citationLeighl, N. B., Raez, L. E., Besse, B., Rosen, P. J., Barlési, F., Massarelli, E., Gabrail, N. Y., Hart, L. L., Albain, K. S., Berkowitz, L., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181e2f7fb · Cited by 89
Gabriels, K., Hoving, S., Seemann, I., Visser, N. L., Gijbels, M. J., Pol, J. F., Daemen, M. J. A. P., Stewart, F. A., & Heeneman, S. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.08.002 · Cited by 84
Barjaktarović, Ž., Shyla, A., Azimzadeh, O., Schulz, S., Haagen, J., Dörr, W., Sarioglu, H., Atkinson, M. J., Zischka, H., & Tapio, S. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.01.017 · Cited by 80
Jarfelt, M., Kujacic, V. G., Holmgren, D., Bjarnason, R. G., & Lannering, B. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21289 · Cited by 75
Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease
van Leeuwen-Segarceanu, E. M., Bos, W. J. W., Dorresteijn, L. D. A., Rensing, B. J. W. M., der Heyden, J. A. S. V., Vogels, O. J. M., & Biesma, D. H. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.12.004 · Cited by 71
Tarantini, L., Gori, S., Faggiano, P. M., Pulignano, G., Simoncini, E., Tuccia, F., Ceccherini, R., Bovelli, D., Lestuzzi, C., & Cioffi, G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds127 · Cited by 66
Kruit, W. H. J., Punt, K. J., Goey, S. H., de Mulder, P. H., Hoogenhuyze, D. C. A. V., Henzen‐Logmans, S. C., & Stoter, G. (1994) · Cancer · Cited by 55
Ma, L., Gul, R., Habibi, J., Yang, M. J., Pulakat, L., Whaley‐Connell, A. T., Ferrario, C. M., & Sowers, J. R. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01126.2011 · Cited by 53
Cardiovascular disease associated with radiotherapy: activation of nuclear factor kappa-B
Halle, M., Hall, P. N., & Tornvall, P. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02353.x · Cited by 49
Hoving, S., Heeneman, S., Gijbels, M. J., Poele, J. A. M. T., Visser, N. L., Cleutjens, J. P. M., Russell, N. S., Daemen, M. J. A. P., & Stewart, F. A. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.11.001 · Cited by 49
Hoving, S., Heeneman, S., Gijbels, M. J., Poele, J. A. M. T., Pol, J. F., Gabriels, K., Russell, N. S., Daemen, M. J. A. P., & Stewart, F. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.09.019 · Cited by 36
Černý, J., Hassan, A., Smith, C., & Piperdi, B. (2009) · Clinical Colorectal Cancer · doi:10.3816/ccc.2009.n.009 · Cited by 36
Cardiotoxicity in Patients Treated With Bevacizumab Is Potentially Reversible
Hawkes, E. A., Okines, A. F. C., Plummer, C., & Cunningham, D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5008 · Cited by 33
Heart Failure Associated with Sunitinib: Lessons Learned from Animal Models
Greineder, C. F., Kohnstamm, S., & Ky, B. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0225-8 · Cited by 30
Sawaya, H., Plana, J. C., & Scherrer‐Crosbie, M. (2011) · Heart Failure Clinics · doi:10.1016/j.hfc.2011.03.003 · Cited by 23
Santoro, F., Ieva, R., Lupo, P., Pellegrino, P. L., Correale, M., Biase, M. D., & Brunetti, N. D. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.070 · Cited by 14
Eder, V., Herault, S., Hudelo, C., Giraudeau, B., Marchal, C., Quilliet, L., Pottier, J.-M., & Arbeille, P. L. (2000) · European Journal of Ultrasound · doi:10.1016/s0929-8266(00)00077-x · Cited by 2
Cited by
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Self-citationZamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Cardiovascular Disease in Women: Clinical Perspectives
Garcia, M., Mulvagh, S. L., Bairey Merz, C. N., Buring, J. E., & Manson, J. E. (2016) · Circulation Research · doi:10.1161/circresaha.116.307547 · Cited by 1,080
Self-citationMehta, L. S., Watson, K. E., Barac, A., Beckie, T. M., Bittner, V., Cruz-Flores, S., Dent, S., Kondapalli, L., Ky, B., Okwuosa, T., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000556 · Cited by 848
Metadata
- Authors
- Herrmann, J., Lerman, A., Sandhu, N. P., Villarraga, H. R., Mulvagh, S. L., & Kohli, M.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 89
- Issue
- 9
- Pages
- 1287-1306
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2123380464
- Cited by
- 422
- References
- 116
- FWCI
- 16.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.